The use of Paxlovid may be beneficial for adult COVID-19 patients who do not require supplemental oxygen and who are at high risk of progression to severe COVID-19Information on Using Paxlovid for the Treatment of COVID-19There is no drug approved by the Food and Drug Administration (FDA) to specifically treat COVID-19. The use of Paxlovid may be beneficial for adult COVID-19 patients who do not require supplemental oxygen and who are at high risk of progression to severe COVID-19.
The following Patient Information Leaflet (PIL) contains information regarding the benefits and risks of using Paxlovid. Please consult your healthcare professional if you have any further questions.
Information regarding the drug Paxlovid can be downloaded at the following link.
Paxlovid Leaflet Material (Nirmatrelvir 150, Ritonavir 100)
1 document 654.83 KB
